|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 22 October 2003
doi: 10.1242/dev.00831
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Institute of Molecular Medicine and Department of Medicine, School of Medicine, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0641, USA
* Author for correspondence (e-mail: juchen{at}ucsd.edu)
Accepted 27 August 2003
The requirement for atrial function in developing heart is unknown. To address this question, we have generated mice deficient in atrial myosin light chain 2 (MLC2a), a major structural component of the atrial myofibrillar apparatus. Inactivation of the Mlc2a gene resulted in severely diminished atrial contraction and consequent embryonic lethality at ED10.5-11.5, demonstrating that atrial function is essential for embryogenesis. Our data also address two longstanding questions in cardiovascular development: the connection between function and form during cardiac morphogenesis, and the requirement for cardiac function during vascular development. Diminished atrial function in MLC2a-null embryos resulted in a number of consistent secondary abnormalities in both cardiac morphogenesis and angiogenesis. Our results unequivocally demonstrate that normal cardiac function is directly linked to normal morphogenic development of heart and vasculature. These data have important implications for the etiology of congenital heart disease.
Key words: Myosin light chain 2a, MLC2a, Atria, Cardiac morphogenesis, Angiogenesis, Embryogenesis
Related articles in Development:
This article has been cited by other articles:
![]() |
C. R. McKeown, R. B. Nowak, J. Moyer, M. A. Sussman, and V. M. Fowler Tropomodulin1 Is Required in the Heart but Not the Yolk Sac for Mouse Embryonic Development Circ. Res., November 21, 2008; 103(11): 1241 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chen, W. Huang, T. Dahme, W. Rottbauer, M. J. Ackerman, and X. Xu Depletion of zebrafish essential and regulatory myosin light chains reduces cardiac function through distinct mechanisms Cardiovasc Res, July 1, 2008; 79(1): 97 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Lucitti, E. A. V. Jones, C. Huang, J. Chen, S. E. Fraser, and M. E. Dickinson Vascular remodeling of the mouse yolk sac requires hemodynamic force Development, September 15, 2007; 134(18): 3317 - 3326. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Okunade, M. L. Miller, M. Azhar, A. Andringa, L. P. Sanford, T. Doetschman, V. Prasad, and G. E. Shull Loss of the Atp2c1 Secretory Pathway Ca2+-ATPase (SPCA1) in Mice Causes Golgi Stress, Apoptosis, and Midgestational Death in Homozygous Embryos and Squamous Cell Tumors in Adult Heterozygotes J. Biol. Chem., September 7, 2007; 282(36): 26517 - 26527. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Moss and D. P. Fitzsimons Myosin Light Chain 2 Into the Mainstream of Cardiac Development and Contractility Circ. Res., August 4, 2006; 99(3): 225 - 227. [Full Text] [PDF] |
||||
![]() |
W. Rottbauer, G. Wessels, T. Dahme, S. Just, N. Trano, D. Hassel, C. G. Burns, H. A. Katus, and M. C. Fishman Cardiac Myosin Light Chain-2: A Novel Essential Component of Thick-Myofilament Assembly and Contractility of the Heart Circ. Res., August 4, 2006; 99(3): 323 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kehat, R. Heinrich, O. Ben-Izhak, H. Miyazaki, J. S. Gutkind, and A. Aronheim Inhibition of basic leucine zipper transcription is a major mediator of atrial dilatation Cardiovasc Res, June 1, 2006; 70(3): 543 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Dorner, F. Wegmann, S. Butz, K. Wolburg-Buchholz, H. Wolburg, A. Mack, I. Nasdala, B. August, J. Westermann, F. G. Rathjen, et al. Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development J. Cell Sci., August 1, 2005; 118(15): 3509 - 3521. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Briegel, H. S. Baldwin, J. A. Epstein, and A. L. Joyner Congenital heart disease reminiscent of partial trisomy 2p syndrome in mice transgenic for the transcription factor Lbh Development, July 15, 2005; 132(14): 3305 - 3316. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.A.V. Jones, M.H. Baron, S.E. Fraser, and M.E. Dickinson Measuring hemodynamic changes during mammalian development Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1561 - H1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gros, L. Dupays, S. Alcolea, S. Meysen, L. Miquerol, and M. Theveniau-Ruissy Genetically modified mice: tools to decode the functions of connexins in the heart--new models for cardiovascular research Cardiovasc Res, May 1, 2004; 62(2): 299 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Berdougo, H. Coleman, D. H. Lee, D. Y. R. Stainier, and D. Yelon Mutation of weak atrium/atrial myosin heavy chain disrupts atrial function and influences ventricular morphogenesis in zebrafish Development, December 15, 2003; 130(24): 6121 - 6129. [Abstract] [Full Text] [PDF] |
||||